Chiesi is an international biopharmaceuticals group focused on developing innovative therapeutic solutions for respiratory health, rare diseases, and specialty care. As a certified B Corp committed to sustainability and social responsibility, Chiesi aims to improve people's quality of life while reducing its environmental impact. With over 85 years of experience and a global presence in 31 countries, the company operates multiple R&D hubs worldwide.